To follow up on the similarity between pathway gene expression patterns in breast cancer and brain cancer, we examined how the expression of ATF4 and/or Sirt5 was affected in the glioblastoma cell line LN229 upon glutamine withdrawal. The gene discussed is ATF4; the disease is breast carcinoma.